Therapeutic and safety outcomes of intracoronary nicardipine in coronary artery disease patients: a systematic review

Author:

Rehan Syeda Tayyaba1ORCID,Imran Laiba1,Salim Aqsa1,Javed Syed Owais1,Sohail Aruba1ORCID,Hussain Hassan ul1ORCID,Ahmed Jawad1ORCID,Yasmin Farah1ORCID,Islam Md. Saiful23,Asghar Muhammad Sohaib4ORCID

Affiliation:

1. Department of Internal Medicine, Dow University of Health Sciences, Karachi, 74200, Pakistan

2. Department of Public Health & Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh

3. Centre for Advanced Research Excellence in Public Health, Savar, Dhaka, 1342, Bangladesh

4. Division of Nephrology & Hypertension, Mayo Clinic, Rochester, US 55905, USA

Abstract

Aim: This systematic review aimed to shed light on the efficacy of intracoronary (IC) nicardipine in treating no reflow with CAD undergoing revascularization. Methods: Literature search was performed on databases with following eligibility criteria: adult patients with CAD; clinical trials or observational studies; IC nicardipine as intervention; therapeutic and safety outcome reported. Results: A total of 1249 papers were yielded during the literature search. Of these, 11 studies were finalized for this systematic review. Complete restoration of TIMI 3 flow was observed in 98.6% of the patients receiving IC nicardipine. A significant increase in the CBF after infusion of IC nicardipine (p < 0.05) was also observed. Conclusion: IC nicardipine significantly increases CBF and decreases coronary vascular resistance.

Publisher

Future Medicine Ltd

Subject

Cardiology and Cardiovascular Medicine,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3